Germline gene therapy via SSCs has achieved success in correcting an X-linked testis-expressed 11 (TEX11) mutation in mice with azoospermia phenotype.416 The mutant SSCs were isolated, and the TEX11 mutation was corrected by CRISPR-CAS9 technology. Here, TEX11 is linked to Azoospermia.